Bridges to Access

Breakthrough Medicines for Patients in Need

Bridges to Access, GlaxoSmithKline’s patient assistance program for non-oncology medicines, provides GSK prescription medicines to eligible low-income patients without prescription drug benefits.

GlaxoSmithKline patient assistance programs provided medicines valued at $370 million (valued using Wholesale Acquisition Cost) to 402,000 patients during 2006.

Program Highlights
- Same-day access to GSK drugs following phone enrollment
- No application or enrollment fees
- “Low-to-No” patient co-pays
- Enroll once per year

These are medicines you currently may have access to through Bridges to Access...

  • Advair

  • Advair Diskus

  • Agenerase

  • Albenza

  • Alkeran

  • Altabax

  • Amerge

  • Amoxil

  • Arixtra

  • Augmentin

  • Avandamet

  • Avandaryl

  • Avandia

  • Avodart

  • Bactroban

  • Beconase

  • Boniva

  • Ceftin

  • Combivir

  • Coreg

  • Daraprim

  • Dexedrine

  • Dyazide

  • Epivir

  • Epzicom

  • Flonase

  • Flovent

  • Fortaz

  • Imitrex

  • Lamictal

  • Lanoxicaps

  • Lanoxin

  • Lexiva

  • Malarone

  • Parnate

  • Paxil

  • Relenza

  • Retrovir

  • Serevent

  • Timentin

  • Trizivir

  • Valtrex

  • Ventolin

  • Veramyst

  • Vesicare

  • Wellbutrin

  • Zantac

  • Ziagen

  • Zinacef

  • Zofran

  • Zovirax

  • Zyban

  • Full GlaxoSmithKline Medicine List